Sign Up for Free!

Continue Analyzing the page and more.

Already have an Account? Log In

The Trial has ended

Continue Analyzing the page and more.

NANOMIX Corp logo
NNMX

NANOMIX Corp

MaveScore 25 Low model confidence
Last Price US$0.00 As of Updating
Market Cap US$9800.0 Company size context
7D Performance 0.00% Past 7 days
1Y Performance -99.90% Past 12 months
Model Rating
Historical model output for research review

Fundamental data date

Dec 31, 2023

898 days old

Market price date

Updating

Refreshing

Coverage

13/16

3 missing model inputs

Data quality

Review

Partial or delayed snapshot

Transparent research score

Why the model scores this stock

MaveScore is a research prioritization score from 0 to 100. It is historical model output for watchlist review, not personalized financial advice.

MaveScore 25 Low confidence

Stored data quality

Freshness and coverage checks

Stored company inputs are available, but some dates or model fields are older or incomplete.

13/16 Partial or delayed snapshot

Quality

Quality score blends the latest weighted model rank with underlying profitability and dilution ranks.

13/35 Weak

Financial Strength

Financial strength rewards durable profitability, margins, and positive free cash flow.

11/25 Mixed

Valuation Support

Valuation favors positive earnings, positive cash flow, and lower price-to-book multiples.

0/15 Weak

Momentum

Momentum needs recent 3-month or 6-month price-change data.

0/15 Needs Data

Shareholder Alignment

Shareholder alignment rewards less dilutive share behavior and enough size for liquid research coverage.

1/10 Weak

Positive model output

More live company inputs are needed before positive research signals can be surfaced.

Research risks to review

  • Quality score blends the latest weighted model rank with underlying profitability and dilution ranks.
  • Valuation favors positive earnings, positive cash flow, and lower price-to-book multiples.
  • Momentum needs recent 3-month or 6-month price-change data.

MaveScore uses historical model inputs, stored company fundamentals, and stored price context for research support only. Review missing inputs and business-specific risks before acting. Missing inputs right now include latest price, 3-month price change, 6-month price change.

Dashboard Funda..tals Deep..lue Prediction Screener Map

NANOMIX Corp Overview

Industry: Medical Devices

Sector: Healthcare

Nanomix Corporation develops mobile point-of-care diagnostic system that is used in performing a range of in vitro diagnostic tests in various environments. Its products are designed to improve healthcare delivery by bringing diagnostic information to the point of initial patient interaction, whether in the hospital or in settings, such as nursing facilities, elderly homes, urgent care centers, airports, schools, and others. The company is also developing a pipeline of other tests designed to enhance patient outcomes by making diagnostic information available. Nanomix Corporation was founded in 2000 and is headquartered in San Leandro, California.

NANOMIX Corp is evaluated using Mavefund's quality framework: growing earnings, durable profit margins, conservative leverage, strong return on equity, and disciplined share repurchases.

Score

Price History & Performance

Review NANOMIX Corp in context before unlocking the interactive price chart, financial overlays, and downloadable ratio tables.

Recent News



NANOMIX Corp Competitors

NANOMIX Corp operates in the Medical Devices industry within the Healthcare sector. Unlock the full page to compare peer rankings, valuation quality, profitability, leverage, and growth trends.

Earnings Per Share

EPS quality is one of the core Mavefund signals. Sign up to continue into the detailed EPS, ROE, margin, share buyback, leverage, and financial ratio analysis.

Continue the analysis

Sign up to unlock ROE, net margin, share buyback, leverage, financial ratios, peer charts, and downloads.

View plans
Ticker Image

NANOMIX Corp

US$0.00

US$9800.0

0.00%

-99.90%